Determining treatment intensity in elderly patients with multiple myeloma.

Salvini M et al. Expert Rev Anticancer Ther. 2018 Sep. doi: 10.1080/14737140.2018.1496823. [Epub 2018 Jul 13]

Treatment patterns and medication adherence among patients diagnosed with multiple myeloma and treated with panobinostat.

Chari A et al. Future Oncol. 2018 Sep. doi: 10.2217/fon-2017-0727. [Epub 2018 May 30]

Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.

Aggarwal M et al. Ann Hematol. 2018 Oct. doi: 10.1007/s00277-018-3370-1. [Epub 2018 May 21]

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Strati P et al. Haematologica. 2018 Sep. doi: 10.3324/haematol.2018.187617. [Epub 2018 Apr 5]

In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects.

Li Y et al. J Clin Pharmacol. 2018 Oct. doi: 10.1002/jcph.1145. [Epub 2018 May 15]